Personalized Medicine in Kidney Transplantation and Immunology
A special issue of Journal of Personalized Medicine (ISSN 2075-4426).
Deadline for manuscript submissions: closed (25 July 2022) | Viewed by 26423
Special Issue Editor
Special Issue Information
Dear Colleagues,
Transplantation in the last century has been the most potent and successful driver to study the immune system and the genetic individuality of HLA. These discoveries have led to clinical application of transplantation, saving life of patients affected by terminal organ failure. Organ transplantation has also driven the development of immunosuppressive agents to control activation of the immune system, so preventing acute rejection of transplanted organs, also allowing treatment of many autoimmune diseases. Today, renal transplantation is the best treatment available for patients with end stage renal disease. Transplantation saves life, but we still have the task to optimize results by personalizing our treatment approach. Personalized medicine is today one of the most important task of modern medicine, and it is absolutely clear that transplantation, by its nature, is the best examples of applied personalized medicine, as we personalize organ allocation and the immunosuppressive strategy in our patients.
We are inviting you to participate in this discussion on personalized medicine, submitting your personal experience or personal view to be published in the special number of Journal of Personalized Medicine dedicated to “Renal transplantation and immunology”.
Dr. Franco Citterio
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Renal transplantation
- Immunosuppression
- Organ allocation
- Infections
- Organ preservation
- Quality of life
- Costs of transplantation
- Hyperimmunized patient
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.